Werewolf Therapeutics
Tracked across 1 events · 6 articles · First seen Aug 21, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Werewolf Therapeutics is the acquiring entity in the all-stock merger, with its stock surging over 100% on the announcement. The deal implies a relatively low valuation of $47.5 million, and pre-merger stockholders will own only about 6.8% of the combined company.
Aug 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Werewolf Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard